Rheos Medicines

Rheos Medicines, Inc. is a biopharmaceutical company based in Cambridge, Massachusetts, founded in 2017. The company focuses on developing novel therapeutics that modulate metabolic pathways in immune cells to address immune-mediated diseases, such as inflammatory bowel disease, rheumatoid arthritis, and lupus. By targeting the cellular metabolism of specific immune cell types, Rheos aims to redirect their function and fate, thereby enhancing treatment precision. The company combines the expertise of leading scientists in immunometabolism with experienced clinicians and a seasoned leadership team to identify new drug targets and characterize disease biomarkers, ultimately striving to improve outcomes for patients suffering from autoimmune conditions.